Skip to main content
logo
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
China flag China · Delayed Price · Currency is CNY
16.47
+0.08 (0.49%)
Sep 4, 2026, 3:04 PM CST

SHE:000766 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
487.93272.1274.18177.45336.82301.59
Trading Asset Securities
1.041.071.091.050.130.18
Cash & Short-Term Investments
488.97273.18275.27178.49336.95301.77
Cash Growth
41.83%-0.76%54.22%-47.03%11.66%-40.60%
Accounts Receivable
577.99522.05526.27520.31470.42397.13
Other Receivables
11.9316.215.3334.8135.7661.52
Receivables
589.91538.26541.6555.12506.18458.65
Inventory
345.76365.2382.19369.17381.37384.58
Prepaid Expenses
-0.63----
Other Current Assets
15.517.9210.918.4313.876.68
Total Current Assets
1,4401,1951,2101,1111,2381,152
Property, Plant & Equipment
980.04999.53989.841,0261,0531,087
Long-Term Investments
1,8541,8531,8481,9861,9891,989
Goodwill
1.91.91.91.91.91.91
Other Intangible Assets
391.76171.49184.96201.67216.61233.4
Long-Term Deferred Tax Assets
28.2727.6131.7313.614.6919.33
Long-Term Deferred Charges
1.3220.77190.22173.46160.89153.31
Other Long-Term Assets
8.387.0326.945.8510.475.37
Total Assets
4,7064,4774,4844,5194,6854,641

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
146.65123.02182.31191221.79150.59
Accrued Expenses
33.5537.7531.6334.8448.2338.79
Short-Term Debt
284.27216.75194.75130.1625.0440.06
Current Portion of Long-Term Debt
152.619.491,6058.26204.591,625
Current Portion of Leases
0.170.180.174.60.290.26
Current Income Taxes Payable
20.197.542.555.520.79
Current Unearned Revenue
12.9910.7114.6611.6639.7911.5
Other Current Liabilities
108.18115.11121.26189.42126.6160.79
Total Current Liabilities
740.41513.192,157572.49671.862,028
Long-Term Debt
1,5821,586-1,5571,564183.75
Long-Term Leases
2.672.632.832.144.443.98
Long-Term Unearned Revenue
61.3262.5465.5364.7571.8378.9
Long-Term Deferred Tax Liabilities
1.441.912.994.364.947.3
Total Liabilities
2,3882,1662,2282,2012,3172,301

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
966.49966.49966.49966.49966.49966.49
Additional Paid-In Capital
3,5793,5793,5793,5793,6423,642
Retained Earnings
-2,130-2,137-2,172-2,228-2,272-2,302
Comprehensive Income & Other
-97.86-97.86-118.7---
Total Common Equity
2,3182,3112,2552,3182,3372,307
Minority Interest
-0.17-0.080.010.4631.6432.6
Shareholders' Equity
2,3172,3102,2552,3182,3692,339
Total Liabilities & Equity
4,7064,4774,4844,5194,6854,641

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
2,0221,8151,8021,7031,7981,853
Net Cash (Debt)
-1,533-1,542-1,527-1,524-1,461-1,551
Net Cash Growth
------
Net Cash Per Share
-1.79-1.80-1.62-1.73-1.45-1.76
Filing Date Shares Outstanding
966.49966.49966.49966.49966.49966.49
Total Common Shares Outstanding
966.49966.49966.49966.49966.49966.49
Working Capital
699.73682-946.9538.72566.51-875.86
Book Value Per Share
2.402.392.332.402.422.39
Tangible Book Value
1,9242,1372,0692,1142,1182,071
Tangible Book Value Per Share
1.992.212.142.192.192.14
Buildings
709.47709.47688.35687.85685.07682.42
Machinery
463.69462.89445.26442.19425.08419.56
Construction In Progress
270.05268.86272.26267.94267.39259.15